This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cazorla, S. I.
Right arrow Articles by Guzmán, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cazorla, S. I.
Right arrow Articles by Guzmán, C. A.

 Previous Article  |  Next Article 

Infection and Immunity, January 2008, p. 324-333, Vol. 76, No. 1
0019-9567/08/$08.00+0     doi:10.1128/IAI.01163-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Oral Vaccination with Salmonella enterica as a Cruzipain-DNA Delivery System Confers Protective Immunity against Trypanosoma cruzi{triangledown}

Silvia I. Cazorla,1,2 Pablo D. Becker,3 Fernanda M. Frank,1,2 Thomas Ebensen,3 María J. Sartori,4 Ricardo S. Corral,5 Emilio L. Malchiodi,1,2* and Carlos A. Guzmán3*

Cátedra de Inmunología and Instituto de Estudios de la Inmunidad Humoral, CONICET-UBA, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina,1 Departamento de Microbiología, Parasitología e Inmunología, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina,2 Department of Vaccinology, Helmholtz Centre for Infection Research, Inhoffenstrasse 7, D-38124 Braunschweig, Germany,3 Instituto de Biología Celular, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, Córdoba, Argentina,4 Laboratorio de Virología, Hospital de Niños Ricardo Gutiérrez, Buenos Aires, Argentina5

Received 21 August 2007/ Returned for modification 22 September 2007/ Accepted 21 October 2007

To stimulate both local and systemic immune responses against Trypanosoma cruzi, Salmonella enterica serovar Typhimurium aroA was exploited as a DNA delivery system for cruzipain (SCz). In a murine model we compared SCz alone (GI) or coadministered with Salmonella carrying a plasmid encoding granulocyte-macrophage colony-stimulating factor (GII), as well as protocols in which SCz priming was followed by boosting with recombinant cruzipain (rCz) admixed with either CpG-ODN (GIII) or MALP-2, a synthetic derivative of a macrophage-activating lipopeptide of 2 kDa from Mycoplasma fermentans (GIV). The results showed that protocols that included four oral doses of SCz (GI) elicited mainly a mucosal response characterized by immunoglobulin A (IgA) secretion and proliferation of gut-associated lymphoid tissue cells, with weak systemic responses. In contrast, the protocol that included a boost with rCz plus CpG (GIII) triggered stronger systemic responses in terms of Cz-specific serum IgG titers, splenocyte proliferation, gamma interferon (IFN-{gamma}) secretion, and delayed-type hypersensitivity response. Trypomastigote challenge of vaccinated mice resulted in significantly lower levels of parasitemia compared to controls. Protection was abolished by depletion of either CD4+ or CD8+ T cells. Parasite control was also evident from the reduction of tissue damage, as revealed by histopathologic studies and serum levels of enzymes that are markers of muscle injury in chronic Chagas' disease (i.e., creatine kinase, aspartate aminotransferase, and lactate dehydrogenase). Enhanced release of IFN-{gamma} and interleukin-2 was observed in GI and GII upon restimulation of splenocytes in the nonparasitic phase of infection. Our results indicate that Salmonella-mediated delivery of Cz-DNA by itself promotes the elicitation of an immune response that controls T. cruzi infection, thereby reducing parasite loads and subsequent damage to muscle tissues.


* Corresponding author. Mailing address for Emilio L. Malchiodi: Cátedra de Inmunología and Instituto de Estudios de la Inmunidad Humoral, CONICET-UBA, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina. Phone: 5411 4964 8259. Fax: 5411 4964 0024. E-mail: emalchio{at}ffyb.uba.ar. Mailing address for Carlos A. Guzmán: Department of Vaccinology, Helmholtz Centre for Infection Research, Inhoffenstrasse 7, D-38124 Braunschweig, Germany. Phone: 49 531 6181 4600. Fax: 49 531 6181 4699. E-mail: carlos.guzman{at}helmholtz-hzi.de

{triangledown} Published ahead of print on 29 October 2007.

Editor: W. A. Petri, Jr.


Infection and Immunity, January 2008, p. 324-333, Vol. 76, No. 1
0019-9567/08/$08.00+0     doi:10.1128/IAI.01163-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Crager, S. E., Price, M. (2009). Prizes and Parasites: Incentive Models for Addressing Chagas Disease. J Law Med Ethics 37: 292-304  
  • Antoine-Moussiaux, N., Buscher, P., Desmecht, D. (2009). Host-Parasite Interactions in Trypanosomiasis: on the Way to an Antidisease Strategy. Infect. Immun. 77: 1276-1284 [Full Text]  
  • Sukumar, N., Love, C. F., Conover, M. S., Kock, N. D., Dubey, P., Deora, R. (2009). Active and Passive Immunizations with Bordetella Colonization Factor A Protect Mice against Respiratory Challenge with Bordetella bronchiseptica. Infect. Immun. 77: 885-895 [Abstract] [Full Text]  
  • del Rio, B., Dattwyler, R. J., Aroso, M., Neves, V., Meirelles, L., Seegers, J. F. M. L., Gomes-Solecki, M. (2008). Oral Immunization with Recombinant Lactobacillus plantarum Induces a Protective Immune Response in Mice with Lyme Disease. CVI 15: 1429-1435 [Abstract] [Full Text]  
  • Silveira, E. L. V., Claser, C., Haolla, F. A. B., Zanella, L. G., Rodrigues, M. M. (2008). Novel Protective Antigens Expressed by Trypanosoma cruzi Amastigotes Provide Immunity to Mice Highly Susceptible to Chagas' Disease. CVI 15: 1292-1300 [Abstract] [Full Text]